LNAI

Lunai Bioworks

• Benzinga·2h ago

  12 Health Care Stocks Moving In Tuesday's Intraday Session

• Benzinga·6h ago

  Lunai Bioworks' BioSymetrics Launches AI-Enabled Chemical Threat Detection Collaboration, Advancing Dual-Use Biodefense Through Commercial Engagement

• Reuters·6h ago

  Lunai Bioworks unit BioSymetrics wins first revenue-generating defense collaboration

• Benzinga·1d ago

  12 Health Care Stocks Moving In Monday's Intraday Session

• TipRanks·03/30 23:10

  Lunai Bioworks Expands CNS Portfolio With $20M Acquisition

• Reuters·03/30 21:41

  Lunai Bioworks acquires Clemann Group BBB delivery platform in $20M deal

• Benzinga·03/30 21:05

  12 Health Care Stocks Moving In Monday's After-Market Session

• Benzinga·03/26 21:05

  12 Health Care Stocks Moving In Thursday's After-Market Session

• Benzinga·03/26 17:05

  12 Health Care Stocks Moving In Thursday's Intraday Session

• Benzinga·03/26 16:46

  What's Behind The Jump In Lunai Bioworks Stock?

• Seeking Alpha·03/26 13:06

  Lunai Bioworks completes $20M transaction to acquire BBB

• TipRanks·03/26 12:55

  Lunai Bioworks acquires BBB delivery platform in Alzheimer’s for $20M

• Benzinga·03/26 12:53

  Lunai Bioworks Executes $20M Transaction To Acquire Blood-Brain Barrier Delivery Technology And Central Nervous System Alzheimer's Drug Assets From Clemann Group

• Reuters·03/26 12:51

  Lunai Bioworks acquires Clemann Group BBB delivery technology and CNS Alzheimer’s assets; deal totals $20 million at $1.50 conversion price

• Dow Jones·03/26 12:50

  Press Release: Lunai Bioworks Executes $20M Strategic Transaction at Fixed $1.50 Conversion, Acquiring BBB Delivery Platform for CNS Alzheimer's Therapies with Broad CNS Delivery Applications